These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18983415)

  • 1. Mycobacterium chelonae necrotizing pneumonia after allogeneic hematopoietic stem cell transplant: report of clinical response to treatment with tigecycline.
    Peres E; Khaled Y; Krijanovski OI; Mineishi S; Levine JE; Kaul DR; Riddell J
    Transpl Infect Dis; 2009 Feb; 11(1):57-63. PubMed ID: 18983415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of resistance to clarithromycin during treatment of disseminated cutaneous Mycobacterium chelonae infection: case report and literature review.
    Vemulapalli RK; Cantey JR; Steed LL; Knapp TL; Thielman NM
    J Infect; 2001 Oct; 43(3):163-8. PubMed ID: 11798252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mycobacterium chelonae cutaneous infection: efficacy of prolonged treatment by clarithromycin].
    Bordet AL; Machet L; De Muret A; François-Ramanantsoa C; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1997; 124(3):251-3. PubMed ID: 9686059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated cutaneous Mycobacterium chelonae infection in an immunocompetent host.
    Halpern J; Biswas A; Cadwgan A; Tan BB
    Clin Exp Dermatol; 2010 Apr; 35(3):269-71. PubMed ID: 20500199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cutaneous infection due to Mycobacterium chelonae in a hemodialysed patient].
    Drouineau O; Rivault O; Le Roy F; Martin-Passos E; Young P; Godin M
    Nephrol Ther; 2006 Jul; 2(3):136-9. PubMed ID: 16890138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and treatment of infection due to mycobacterium fortuitum/chelonae complex.
    McFarland EJ; Kuritzkes DR
    Curr Clin Top Infect Dis; 1993; 13():188-202. PubMed ID: 8397910
    [No Abstract]   [Full Text] [Related]  

  • 7. [Case of pulmonary infection with Mycobacterium chelonae in healthy breast-feeding woman].
    Suzuki K; Matsuki A; Saito K; Tanaka Y
    Kekkaku; 2007 Oct; 82(10):759-63. PubMed ID: 18018600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of disseminated Mycobacterium chelonae infection with linezolid.
    Brown-Elliott BA; Wallace RJ; Blinkhorn R; Crist CJ; Mann LB
    Clin Infect Dis; 2001 Oct; 33(8):1433-4. PubMed ID: 11550122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tigecycline for the treatment of Acinetobacter infections: a case series.
    Gallagher JC; Rouse HM
    Ann Pharmacother; 2008 Sep; 42(9):1188-94. PubMed ID: 18614749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cutaneous non-tuberculous mycobacterial infection following cord blood stem cell transplantation].
    Yanagimachi M; Goto H; Yokosuka T; Kajiwara R; Fujii H; Kuroki F; Ito S; Yokota S; Taniguchi A; Shigehira Y; Ikezawa Z; Inayama Y
    Rinsho Ketsueki; 2008 Feb; 49(2):99-103. PubMed ID: 18341040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pleuropneumonia due to Mycobacterium chelonae].
    Schubel K; Bassinet L; Monnet I; Jabot L; Atassi K; Honoré I; Maître B; Housset B; Mangiapan G
    Rev Mal Respir; 2011 Mar; 28(3):348-51. PubMed ID: 21482339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synchronous infection with Mycobacterium chelonae and Paecilomyces in a heart transplant patient.
    Kim JE; Sung H; Kim MN; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
    Transpl Infect Dis; 2011 Feb; 13(1):80-3. PubMed ID: 20412536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro sensitivity of Mycobacterium chelonae strains to various antimicrobial agents].
    Hernández García AM; Arias A; Felipe A; Alvarez R; Sierra A
    Microbiologia; 1995 Dec; 11(4):485-90. PubMed ID: 8588844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of nodular lymphangitis due to Mycobacterium chelonae in two immunosuppressed patients.
    Schneider P; Monsel G; Veziris N; Roujeau JC; Bricaire F; Caumes E
    Dermatol Online J; 2011 Mar; 17(3):8. PubMed ID: 21426874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated cutaneous Mycobacterium chelonae infection with multidrug resistance in a patient with panuveitis.
    Phillips K; Blackford S; Berry N
    Clin Exp Dermatol; 2008 May; 33(3):256-8. PubMed ID: 18021269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.
    Bergallo C; Jasovich A; Teglia O; Oliva ME; Lentnek A; de Wouters L; Zlocowski JC; Dukart G; Cooper A; Mallick R;
    Diagn Microbiol Infect Dis; 2009 Jan; 63(1):52-61. PubMed ID: 18990531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model.
    Koomanachai P; Kim A; Nicolau DP
    J Antimicrob Chemother; 2009 May; 63(5):982-7. PubMed ID: 19279050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservative management of local Mycobacterium chelonae infection after combined liposuction and lipofilling.
    Dessy LA; Mazzocchi M; Fioramonti P; Scuderi N
    Aesthetic Plast Surg; 2006; 30(6):717-22. PubMed ID: 17093877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lung as a target organ of graft-versus-host disease.
    Yanik G; Cooke KR
    Semin Hematol; 2006 Jan; 43(1):42-52. PubMed ID: 16412788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia.
    Tanaseanu C; Bergallo C; Teglia O; Jasovich A; Oliva ME; Dukart G; Dartois N; Cooper CA; Gandjini H; Mallick R; ;
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):329-38. PubMed ID: 18508226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.